NYSE:DVA - Davita Stock Price, Forecast & News

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita Inc (NYSE:DVA) released its quarterly earnings data on Monday, February, 10th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.20. The company earned $2.90 billion during the quarter, compared to the consensus estimate of $2.92 billion. Davita had a net margin of 7.12% and a return on equity of 25.18%. Davita's revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.90 earnings per share. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Davita.

Davita issued an update on its FY20 earnings guidance on Monday, February, 10th. The company provided earnings per share (EPS) guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.58. The company issued revenue guidance of $11.50-11.70 billion, compared to the consensus revenue estimate of $11.57 billion.

10 brokerages have issued 1-year target prices for Davita's stock. Their forecasts range from $57.00 to $90.00. On average, they anticipate Davita's stock price to reach $67.83 in the next twelve months. This suggests that the stock has a possible downside of 12.6%. View Analyst Price Targets for Davita.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Headlines about DVA stock have trended very negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Davita earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next several days. View News Stories for Davita.

Davita saw a decrease in short interest in February. As of February 14th, there was short interest totalling 6,810,000 shares, a decrease of 12.1% from the January 30th total of 7,750,000 shares. Based on an average trading volume of 1,360,000 shares, the days-to-cover ratio is currently 5.0 days. Approximately 5.4% of the company's stock are sold short. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Designer Brands (DBI).

Davita's stock is owned by many different of institutional and retail investors. Top institutional investors include State Street Corp (3.72%), Bank of New York Mellon Corp (1.71%), Geode Capital Management LLC (1.33%), Thornburg Investment Management Inc. (0.77%), Boston Partners (0.67%) and Renaissance Technologies LLC (0.64%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., FMR LLC, State Street Corp, Thornburg Investment Management Inc., Bank of Montreal Can, DekaBank Deutsche Girozentrale, Jarislowsky Fraser Ltd and UBS Group AG. View Insider Buying and Selling for Davita.

DVA stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, AQR Capital Management LLC, Covenant Multifamily Offices LLC, Schroder Investment Management Group, Great West Life Assurance Co. Can, Prudential Financial Inc., Mackay Shields LLC and Renaissance Technologies LLC. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $77.62.

Davita has a market capitalization of $9.75 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]